Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. 1993

T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
Department of Pharmacy, Hyogo College of Medicine, Japan.

The effect of a high-fat meal on the bioavailability of free acid phenytoin (DPH) from Hydantol powder with a large particle size (mean particle size, 190 microns) was investigated in four healthy male subjects. The drug was administered as a single oral 5 mg/kg dose of free acid DPH in the fasting state, with a low-fat meal, or with a high-fat meal using a crossover study design. Seven blood samples were collected over a 34-h period following drug administration, and the drug plasma concentrations were determined by GLC. In comparison with the fasting state results, the mean area under the plasma concentration-time curve up to infinity after administration (AUC0-infinity) and the peak plasma concentration (Cmax) of DPH from Hydantol powder significantly increased about 2-fold with the intake of the high-fat meal and about 1.5-fold with the intake of the low-fat meal. The elimination rate constant was not significantly different among the three treatments. The increased bioavailability with the high-fat meal probably resulted from accelerated dissolution of the poorly soluble Hydantol powder due to the stimulation of bile flow or delay of the gastric emptying time caused by the fat intake.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
January 1989, Journal of clinical pharmacology,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
April 1979, Die Pharmazie,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
October 1986, Chemical & pharmaceutical bulletin,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
November 1999, Journal of clinical pharmacology,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
June 1975, European journal of clinical pharmacology,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
March 2004, Poultry science,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
April 2023, Fundamental & clinical pharmacology,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
June 2005, Antimicrobial agents and chemotherapy,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
April 2009, International journal of clinical pharmacology and therapeutics,
T Hamaguchi, and D Shinkuma, and T Irie, and Y Yamanaka, and Y Morita, and B Iwamoto, and K Miyoshi, and N Mizuno
November 2013, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!